(+49) 381 494-5066
English
Deutsch
NewsContact
CORE FACILITY
Goody D, Engelmann D, Mikkat S, Gupta SK, Pützer BM.
Identification of novel anti-metastatic drugs targeting oncogenic E2F1:coregulatory complexes by applying a systems pharmacology approach.
Cancer Res 76(7 Suppl):Abstract nr B27.
2016
Previous Post
Epigenetic master regulator EPC1 is a decisive factor for E2F1 to silence cell death and activate metastatic gene signatures in response to DNA damage.
Next Post
A conserved E2F1-activated gene regulatory network encompassing monocarboxylic acid transporter-1, its co-operating antisense lncRNA SLC16A1-AS1 and their common downstream targets mediates bladder cancer invasiveness.

Contact

Institute of Experimental Gene Therapy and Cancer Research
Core-Facility Viral Vector & Genome-Editing Technologies
Biomedical Research Center
Schillingallee 69
D-18057 Rostock

Office

Ingrid Winkler
    (+49) 381 494-5066
    (+49) 381 494-5062
    ingrid.winkler@med.uni-rostock.de
Department Life, Light & Matter
Research Building LL&M
Albert-Einstein-Str. 25
D-18059 Rostock
Menu